Notícias

Produtos
IFU
EN-pt
EN-pt
Casa>Notícias

Introdução de cateter venoso central antimicrobiano

2022-07-28
LEPU
Introdução de cateter venoso central antimicrobiano

Lepu's Antimicrobial Central Venous Catheter is the first medicated central venous catheter market in China. Since its official launch in 2008, it has been used in millions of clinical cases.



Why It Is Recommended To Use Antimicrobial Central Venous Catheter?

In clinical practice, Kit cateter venoso central is commonly used to rescue critically ill patients with severe shock, dehydration, blood loss, and hypovolemia. Monitoring of central venous pressure can guide clinicians in diagnosing and treating patients, so it is often necessary to retain or prolong the indwelling time of the catheter. 


However, the operation time of central venous puncture is short, the patient's body resistance is low, immunity is weak, and trauma is large. With the widespread use of central venous catheters, the consequent infection rate has increased significantly, and the mortality rate of patients has increased. Clinically, central venous catheters have been listed as a common source of infection, so the choice of an Antimicrobial Central Venous Catheter with a bacteriostatic effect can reduce the incidence of infection in patients.


antimicrobial-central-venous-cather-1.jpg



Benefícios e Vantagens do Cateter Venoso Central Antimicrobiano Médico Lepu

The disposable Antimicrobial Central Venous Catheter produced by Lepu Fabricante do equipamento médico is based on the traditional central venous catheter and is coated with two antibiotics, rifampicin and minocycline hydrochloride. Among them, rifampicin is a semi-synthetic broad-spectrum antibacterial drug of rifampicin. It has an inhibitory effect on aerobic gram-positive bacteria and aerobic gram-negative bacteria. Minocycline Hydrochloride is a semi-synthetic tetracycline broad-spectrum antibiotic with high efficacy and long-term effect. It has an inhibitory effect on Staphylococcus aureus, Streptococcus, etc., and Gram-negative bacteria. Combining these two drugs produces a complementary antibacterial effect, which can achieve an excellent antibacterial effect. It has been documented that the drug CVC can reduce the incidence of CRABSI by 90%. 


Lepu Medical's Produtos críticos do cuidado like the Antimicrobial Central Venous Catheter is available in various sizes and is suitable for different types of patients, providing more options for doctors. The connection between the catheter and the extension tube adopts the patented technology, which has solved the leakage and seepage problems of similar products on the market.



O uso clínico de cateteres venosos centrais medicados pode reduzir significativamente a incidência de infecção em pacientes, o que também é uma nova medida preventiva para prevenir complicações infecciosas e disputas médicas desnecessárias. O cateter venoso central antimicrobiano produzido por Lepu tem as vantagens do bom projeto, segurança, eficácia, espectro antibacteriano largo, tempo antibacteriano longo, nenhuma reação alérgica, pode reduzir o ciclo de aplicação de antibióticos sistemáticos, e tem o valor clínico alto da aplicação.



Para mais informações:https://en.lepumedical.com/products/safecath-plus-antimicrobial-central-venous-catheter-kit/


Enviar